Fairfax Financial Holdings Ltd (FFH.U.TO)
1142.85
+9.32
(+0.82%)
USD |
TSX |
May 16, 16:00
Fairfax Financial Holdings Enterprise Value: 33.95B for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 33.95B |
May 15, 2024 | 33.74B |
May 14, 2024 | 33.74B |
May 13, 2024 | 28.36B |
May 10, 2024 | 28.61B |
May 09, 2024 | 28.61B |
May 08, 2024 | 28.61B |
May 07, 2024 | 28.61B |
May 06, 2024 | 28.61B |
May 03, 2024 | 28.61B |
May 02, 2024 | 28.61B |
May 01, 2024 | 28.61B |
April 30, 2024 | 28.61B |
April 29, 2024 | 28.61B |
April 26, 2024 | 28.61B |
April 25, 2024 | 28.61B |
April 24, 2024 | 28.61B |
April 23, 2024 | 28.61B |
April 22, 2024 | 28.61B |
April 19, 2024 | 28.61B |
April 18, 2024 | 28.61B |
April 17, 2024 | 28.61B |
April 16, 2024 | 28.61B |
April 15, 2024 | 28.61B |
April 12, 2024 | 28.61B |
Date | Value |
---|---|
April 11, 2024 | 28.61B |
April 10, 2024 | 28.61B |
April 09, 2024 | 28.61B |
April 08, 2024 | 28.61B |
April 05, 2024 | 28.61B |
April 04, 2024 | 28.61B |
April 03, 2024 | 28.61B |
April 02, 2024 | 28.61B |
April 01, 2024 | 28.61B |
March 31, 2024 | 28.61B |
March 28, 2024 | 29.25B |
March 27, 2024 | 29.25B |
March 26, 2024 | 29.25B |
March 25, 2024 | 29.25B |
March 22, 2024 | 29.25B |
March 21, 2024 | 29.25B |
March 20, 2024 | 29.25B |
March 19, 2024 | 29.25B |
March 18, 2024 | 29.25B |
March 15, 2024 | 29.25B |
March 14, 2024 | 29.25B |
March 13, 2024 | 29.25B |
March 12, 2024 | 29.25B |
March 11, 2024 | 29.25B |
March 08, 2024 | 29.25B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-232.38M
Minimum
Mar 07 2022
33.95B
Maximum
May 16 2024
15.67B
Average
14.37B
Median
Nov 25 2019
Enterprise Value Benchmarks
Cypherpunk Holdings Inc | 16.31M |
Armada Mercantile Ltd | 2.453M |
New Frontier Ventures Inc | 0.2521M |
Xtacy Therapeutics Corp | 2.473M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 776.50M |
Revenue (Quarterly) | 6.618B |
Total Expenses (Quarterly) | 5.562B |
EPS Diluted (Quarterly) | 30.82 |
Profit Margin (Quarterly) | 11.73% |
Earnings Yield | 13.54% |
Normalized Earnings Yield | 11.87 |